Premir - blood based breast cancer screening test
Preferred Medicine is a precision oncology company that aims provide early detection, prognosis and monitoring of cancer from a single blood test. Premir it's initial blood based liquid biopsy product focused on high-risk breast cancer; will be launching as an LDT in Q1 of 2022. Preferred Medicine technology is based on miRNA and proprietary unique machine learning algorithm; which provides improved sensitivity and specificity making it the best in class for early detection liquid biopsy products. Preferred Medicine is based in the Bay Area, CA and was founded in 2018.
...
More Info Less Info